BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PYVOBJECT//NONSGML Version 1//EN
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:STANDARD
DTSTART:20001029T030000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10
TZNAME:CET
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20000326T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3
TZNAME:CEST
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:20260726T065936Z - 83096@eupv304
DTSTART;TZID=Europe/Brussels:20240530T091500
DTEND;TZID=Europe/Brussels:20240531T190000
CREATED:20260726T065936Z
DESCRIPTION:<a href="https://www.analis.com/event/recent-insights-into-immu
 no-oncology-20/register">Recent insights into Immuno-Oncology</a>\nREGISTE
 R NOW JOIN US COME TO MEET THE EXPERTS OF ANALIS & BECKMAN COULTER Cancer 
 immunotherapy has revolutionized the clinical practice in multiple advance
 d cancers and is a fast-developing field in oncology. Over the past decade
 \, we witnessed an extraordinary development and progress in the field of 
 onco-immunology. The ever-expanding knowledge of the processes beyond the 
 success of immunotherapy has leveraged novel biomarkers\, next-generation 
 cell therapies\, cancer vaccines\, and multi-specific antibodies\, among o
 ther clinically relevant advances. At the second edition\, leading experts
  in cancer immunotherapy will present the latest advances in their cutting
 -edge research\, discuss the future challenges in the field of onco-immuno
 logy\, including resistance mechanisms and how to harness cellular and mol
 ecular or metabolic components of complex immune networks to optimize the 
 combination of immunotherapy with other anticancer regimens and develop ne
 w strategies. Compared with the first edition\, the current second onco-im
 munology conference will focus on cellular therapies (CAR\, ACT\, etc.) an
 d clinical trials\, with the main aim to bring researchers closer to the m
 ost recent applications in immunotherapy. We anticipate that the conferenc
 e will provide a landmark forum to stimulate discussion and interaction am
 ong participants\, researchers\, healthcare professionals\, and experts in
  this burgeoning and rapidly evolving field. THE PROGRAM brings together w
 orld-recognized experts who will present their recent work in sessions foc
 used on: Car T Cells Precision immuno-oncology Immune-escape Glycobiology 
 in cancer Cross-talk myeloid cells Tumor-host interactions Translational r
 esearch Next to an inspiring scientific program\, conference participants 
 will have ample networking opportunities during the breaks\, poster sessio
 ns\, and the conference dinner in a perfectly safe and [...]
DTSTAMP:20260726T065936Z
LOCATION:12 Van Diepenbeeckstraat\, ANTWERPEN  2017
SUMMARY:Recent insights into Immuno-Oncology
X-ALT-DESC;FMTTYPE=text/html:<a href="https://www.analis.com/event/recent-i
 nsights-into-immuno-oncology-20/register">Recent insights into Immuno-Onco
 logy</a>\nREGISTER NOW JOIN US COME TO MEET THE EXPERTS OF ANALIS & BECKMA
 N COULTER Cancer immunotherapy has revolutionized the clinical practice in
  multiple advanced cancers and is a fast-developing field in oncology. Ove
 r the past decade\, we witnessed an extraordinary development and progress
  in the field of onco-immunology. The ever-expanding knowledge of the proc
 esses beyond the success of immunotherapy has leveraged novel biomarkers\,
  next-generation cell therapies\, cancer vaccines\, and multi-specific ant
 ibodies\, among other clinically relevant advances. At the second edition\
 , leading experts in cancer immunotherapy will present the latest advances
  in their cutting-edge research\, discuss the future challenges in the fie
 ld of onco-immunology\, including resistance mechanisms and how to harness
  cellular and molecular or metabolic components of complex immune networks
  to optimize the combination of immunotherapy with other anticancer regime
 ns and develop new strategies. Compared with the first edition\, the curre
 nt second onco-immunology conference will focus on cellular therapies (CAR
 \, ACT\, etc.) and clinical trials\, with the main aim to bring researcher
 s closer to the most recent applications in immunotherapy. We anticipate t
 hat the conference will provide a landmark forum to stimulate discussion a
 nd interaction among participants\, researchers\, healthcare professionals
 \, and experts in this burgeoning and rapidly evolving field. THE PROGRAM 
 brings together world-recognized experts who will present their recent wor
 k in sessions focused on: Car T Cells Precision immuno-oncology Immune-esc
 ape Glycobiology in cancer Cross-talk myeloid cells Tumor-host interaction
 s Translational research Next to an inspiring scientific program\, confere
 nce participants will have ample networking opportunities during the break
 s\, poster sessions\, and the conference dinner in a perfectly safe and [.
 ..]
END:VEVENT
END:VCALENDAR